학술논문
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial
Document Type
Article
Author
Ogura, Michinori; Sancho, Juan Manuel; Cho, Seok-Goo; Nakazawa, Hideyuki; Suzumiya, Junji; Tumyan, Gayane; Kim, Jin Seok; Lennard, Anne; Mariz, José; Ilyin, Nikolai; Jurczak, Wojciech; Lopez Martinez, Aurelio; Samoilova, Olga; Zhavrid, Edvard; Yañez Ruiz, Eduardo; Trneny, Marek; Popplewell, Leslie; Coiffier, Bertrand; Buske, Christian; Kim, Won-Seog; Lee, Sang Joon; Lee, Sung Young; Bae, Yun Ju; Kwak, Larry W
Source
In The Lancet Haematology November 2018 5(11):e543-e553
Subject
Language
ISSN
2352-3026